In addition, we examined the enrichment of repressive histone marks H3K9me2 and H3K27me2 on the promoter of DGAT2 in KDM7A-overexpressing AML12 cells and assessed the development of hepatic steatosis in vivo in KDM7A-overexpressing mice. The gene discussed is KDM7A; the disease is fatty liver disease.